Lirentelimab
Lirentelimab (AK002) is a humanized anti-sialic acid-binding immunoglobulin-like lectin-8 (Siglec-8) antibody that induces apoptosis of IL-5-activated eosinophils and inhibits IL-5-mediated mast cell activation, and is used in the study of refractory inert systemic mastocytosis and allergic conjunctivitis.
Product Specifications
CAS Number
2283348-97-8
Stability
≥ 2 years
Purity
>98% (HPLC)
Molecular Formula
——
Notes
Research use only, not for human use.
Receptor
Apoptosis
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
296024-01 100 µg
2',3'-Dideoxy-3'-thia-cytidine-5'-triphosphate (L isomer), lithium salt
Sign In for Pricing
View Details 296024-02 250 µg
2',3'-Dideoxy-3'-thia-cytidine-5'-triphosphate (L isomer), lithium salt
Sign In for Pricing
View Details 296024-03 500 µg
2',3'-Dideoxy-3'-thia-cytidine-5'-triphosphate (L isomer), lithium salt
Sign In for Pricing
View Details 217697-APC 100 µL
PRKACB, Phosphorylated (Ser338) (cAMP-dependent Protein Kinase Catalytic Subunit beta, PKA C-beta, DKFZp781I2452, MGC41879, MGC9320) (APC) discontinued
Sign In for Pricing
View Details MBS6280301-01 0.2 mL
CABP5, NT (CABP5, CABP3, Calcium-binding protein 5) (FITC)
Sign In for Pricing
View Details